Ljunggren K, Löfgren B, Nordenfelt E
Department of Infectious Diseases, University Hospital of Lund, Sweden.
Scand J Infect Dis. 1988;20(5):485-8. doi: 10.3109/00365548809032495.
Staff from a Department of Infectious Diseases (n = 64) were vaccinated against hepatitis B with HBVax (Merck, Sharp & Dohme), a plasma derived vaccine. Prevaccination testing showed a low prevalence of hepatitis B virus markers (1.4%). Only 1 person showed signs of anamnestic antibody response. Post-exposure prophylaxis and strict hygienic routines are recommended for non-operating hospital staff in areas with low prevalence of hepatitis B virus carriers. The anatomic site of intramuscular administration of the vaccine is discussed. The overall antibody response was low, 83% acquired a protective titer of anti-HBs and only 44% in the age group greater than 40 years of age. Postvaccination testing seems strongly advisable, especially in an older age group.
一个传染病科的64名工作人员接种了血浆源性疫苗“乙肝疫苗(HBVax,默克公司生产)”。接种前检测显示乙肝病毒标志物的流行率较低(1.4%)。只有1人出现回忆性抗体反应迹象。对于乙肝病毒携带者低流行地区的非手术科室医院工作人员,建议进行暴露后预防和严格的卫生程序。文中讨论了疫苗肌肉注射的解剖部位。总体抗体反应较低,83%的人获得了抗-HBs保护性滴度,40岁以上年龄组中只有44%的人获得了该滴度。接种后检测似乎非常有必要,尤其是在老年人群体中。